Series 5 Episode 1 - Revolutionising Lung Cancer Diagnostics: The Promise of Liquid Biopsies

Welcome to Genomics Now, a podcast series where you can learn how genomics is developing in England's NHS. This podcast series is recorded in 2024 and is part of the North Thames Genomic Medicine Services Educational Toolkit. In each bite-sized episode, we explore what is changing in genomics. We answer the questions on genomics we've been asked by different healthcare professionals, discuss how genomics may impact various healthcare roles, and examine how genomics can be used to successfully improve patient care.

In this first episode of our five-part series on liquid biopsies, Dr. Shazia Mahamdallie is joined by Paul Ryves, Programme Director for the North Thames Genomic Medicine Service Alliance. They discuss how the NHS in England is leading the way in adopting cutting-edge genomic technologies, specifically focusing on a new blood test that can guide lung cancer treatments.

Learn about the NHS Genomic Networks of Excellence, the phases of the lung cancer pilot, and how this innovative liquid biopsy test could become a standard of care. 

Don't miss out on this exciting conversation about the future of genomics in healthcare.

For more resources and updates on genomic-based clinical developments and research, visit the North Thames Genomic Medicine Service website. If you enjoyed this episode, share your thoughts and spread the word on social media by tagging the North Thames Genomic Medicine Service.